Patents by Inventor Gautam BAHETI

Gautam BAHETI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for reducing risk of onset of acute graft versus host disease after hematopoietic cell transplantation
    Patent number: 11857610
    Abstract: This disclosure relates to methods for preventing or reducing the risk of development of graft versus host disease (GVHD) in patients receiving hematopoietic cell transplantation (HCT) by particular methods of administering alpha-1 antitrypsin (A1AT or AAT) to patients both prior to and following and HCT procedure. The disclosure also relates to specific methods of treating acute GVHD (aGVHD) after HCT with A1AT.
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: January 2, 2024
    Assignee: CSL Behring LLC
    Inventors: Marc Uknis, Christine Voigt, Gautam Baheti, John Roberts
  • METHODS FOR REDUCING RISK OF ONSET OF ACUTE GRAFT VERSUS HOST DISEASE AFTER HEMATOPOEITIC CELL TRANSPLANTATION
    Publication number: 20210008182
    Abstract: This disclosure relates to methods for preventing or reducing the risk of development of graft versus host disease (GVHD) in patients receiving hematopoietic cell transplantation (HCT) by particular methods of administering alpha-1 antitrypsin (A1AT or AAT) to patients both prior to and following and HCT procedure. The disclosure also relates to specific methods of treating acute GVHD (aGVHD) after HCT with A1AT.
    Type: Application
    Filed: November 30, 2018
    Publication date: January 14, 2021
    Applicant: CSL Behring LLC
    Inventors: Marc UKNIS, Christine VOIGT, Gautam BAHETI, John ROBERTS